By Frank Prenesti
Date: Wednesday 12 Apr 2023
LONDON (ShareCast) - (Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.
Said Darwazah will step down as acting CEO and return to his role as executive chairman.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 1,960.00p |
Change Today | 35.00p |
% Change | 1.82 % |
52 Week High | 2,205.00 |
52 Week Low | 1,722.00 |
Volume | 299,387 |
Shares Issued | 221.89m |
Market Cap | £4,348.95m |
RiskGrade | 125 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 11 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 21-Mar-24 | 10-Aug-23 |
Paid | 03-May-24 | 15-Sep-23 |
Amount | 47.00¢ | 25.00¢ |
Time | Volume / Share Price |
16:35 | 169,283 @ 1,960.00p |
16:35 | 9 @ 1,960.00p |
16:35 | 445 @ 1,960.00p |
16:35 | 2,056 @ 1,960.00p |
16:35 | 410 @ 1,960.00p |
You are here: research